The Canary Islands has administered a total of 37,166 doses of the AstraZeneca vaccine, with data closed until last Sunday, and 40,834 are pending, after the Ministry of Health ordered this Monday to temporarily halt vaccination until the European Medicines Agency (EMA) clarifies whether the drug is related to episodes of thrombosis in about thirty people from several European countries.
Sources from the Ministry of Health of the Government of the Canary Islands point out to Europa Press that after approximately one month of vaccination with AstraZeneca, no contraindication or adverse effect has been registered in the vaccinated people, all in their first dose, since the second is administered at the tenth week and the term has not been covered.
This vaccine has been allocated to people under 55 years of age included in the 'second line' healthcare groups, such as private healthcare personnel, dentists or podiatrists, for example, and 'group 6', which includes teachers and members of police forces and the Civil Guard.
